LEBEL FRANCOIS 4
4 · SPECTRUM PHARMACEUTICALS INC · Filed Feb 24, 2022
Insider Transaction Report
Form 4
LEBEL FRANCOIS
Chief Medical Officer
Transactions
- Sale
Common Stock, $0.001 par value
2022-02-23$0.70/sh−13,466$9,467→ 320,028 total - Sale
Common Stock, $0.001 par value
2022-02-24$0.64/sh−14,708$9,413→ 305,320 total
Holdings
- 7,226(indirect: By 401(k))
Common Stock, $0.001 par value
Footnotes (1)
- [F1]All sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person for the purpose of satisfying tax withholding obligations in connection with restricted stock awards granted by the issuer.